Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0320989 A PROCESS FOR THE PREPARATION OF A GRAFT COPOLYMER COMPRISING A POLYOLEFIN MAIN CHAIN AND ONE OR A MULTIPLE...
The present invention relates to a cascade process for the preparation of a graft copolymer comprising a polyolefin main chain and one or a multiple polymer...
2017/0320987 A PROCESS FOR THE PREPARATION OF A BLOCK COPOLYMER COMPRISING A FIRST POLYOLEFIN BLOCK AND A SECOND POLYMER...
The present invention relates to a cascade process for the preparation of a block copolymer comprising a first type of polyolefin block and at least one type...
2017/0320986 LONG-CHAIN BRANCHED POLYPROPYLENE FOR FILM APPLICATION
The invention relates to a propylene homopolymer or copolymer having a comonomer in the copolymer selected from ethylene, C.sub.4-C.sub.20-alpha olefin, said...
2017/0320985 METHODS FOR SYNTHESIZING ACRYLOYL-BASED COPOLYMERS, TERPOLYMERS
Methods for synthesizing acryloyl-based copolymers. The methods include providing a free radical initiator with a solution including monomeric repeating units,...
2017/0320984 OPTICAL COMPOSITION, CURED PRODUCT, AND OPTICAL ELEMENT
Provided is a cured product having the following characteristics: the dispersion characteristic and secondary dispersion characteristic of refractive indices...
2017/0320983 PROCESS FOR PRODUCING WATER-ABSORBENT POLYMER PARTICLES BY POLYMERIZING DROPLETS OF A MONOMER SOLUTION
The present invention relates to a process for producing water-absorbent polymer particles by polymerizing droplets of a monomer solution comprising less than...
2017/0320982 POLYCARBONATE-BASED THERMOPLASTIC RESIN COMPOSITION AND PRODUCT USING SAME
Disclosed are a thermoplastic resin composition which, through combination of certain compatibilizers, satisfies high-gloss and high-impact properties, does...
2017/0320981 METALLOCENE COMPOUND, CATALYST FOR OLEFIN POLYMER, METHOD FOR PRODUCING OLEFIN POLYMER, AND OLEFIN POLYMER
The invention provides a specific metallocene compound and an olefin polymerization catalyst for use for a catalyst for producing an olefin polymer having a...
2017/0320980 RANDOM-SYNDIOTACTIC BLOCK POLYBUTADIENE AND PREPARATION METHOD THEREOF
The present invention relates to the field of polymer materials. Disclosed are a random-syndiotactic block polybutadiene and preparation method thereof, the...
2017/0320979 Method for preparing a dry cationic hydrogel polymer product, polymer product and its use
The invention relates to a method for preparing a dry cationic hydrogel polymer product. The method comprises polymerisation of a reaction mixture comprising...
2017/0320978 OLEFIN-BASED POLYMER HAVING EXCELLENT MELT STRENGTH AND FILM INCLUDING THE SAME
Provided are an olefin-based polymer having excellent melt strength and a film including the same. The olefin-based polymer according to the present invention...
2017/0320977 OLEFIN POLYMERIZATION CATALYST SYSTEM COMPRISING MESOPOROUS ORGANOSILICA SUPPORT
A catalyst system comprising a combination of: 1) one or more catalyst compounds comprising at least one nitrogen linkage; 2) a support comprising an...
2017/0320976 TETRAHYDRO-AS-INDACENYL CATALYST COMPOSITION, CATALYST SYSTEM, AND PROCESSES FOR USE THEREOF
This invention relates to a compound represented by the formula: T.sub.yLAMX.sub.n-2 wherein: A is a substituted or unsubstituted tetrahydro-as-indacenyl group...
2017/0320975 Synergistic visbreaking composition of peroxide and hydroxylamine ester for increasing the visbreaking efficiency
Synergistic visbreaking composition of peroxide and a hydroxylamine ester for increasing the visbreaking efficiency for polypropylene polymers at melt...
2017/0320974 A PROCESS FOR PREPARING WATER-DISPERSIBLE SINGLE-CHAIN POLYMERIC NANOPARTICLES
The present invention comprises a process for preparing water-dispersible single-chain polymeric nanoparticles, which comprises cross-linking a polymer having...
2017/0320973 POLYMERISATION PROCESS AND POLYMERISATION UNIT COMPRISING A DEGASSING SECTION
The present invention relates to processes and apparatus useful for the production of polymer powder, and in particular to processes and apparatus for the...
2017/0320972 CATALYSTS
Novel catalytic compositions are disclosed comprising symmetrical metallocene catalytic compounds. Also disclosed are uses of such catalytic compositions in...
2017/0320971 OLEFIN POLYMERIZATION CATALYST SYSTEM COMPRISING MESOPOROUS ORGANOSILICA SUPPORT
A catalyst system comprising a combination of: 1) one or more catalyst compounds having at least one nitrogen linkage and at least one oxygen linkage to a...
2017/0320970 PROCESS FOR THE DECOMPOSITION OF BIOMASS-MATERIAL
The present application pertains to a process for the decomposition of biomass-material.
2017/0320969 A METHOD FOR MANUFACTURING MICROFIBRILLATED POLYSACCHARIDE
The present invention relates to a method for manufacturing microfibrillated polysaccharide, preferably microfibrillated cellulose. The invention also relates...
2017/0320968 METHODS AND PRODUCTS FOR INCREASING FRATAXIN LEVELS AND USES THEREOF
Methods and products (e.g., recombinant proteins) are described for increasing frataxin expression/levels in a cell, as well as uses of such methods and...
2017/0320967 TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS
The disclosure provides trispecific and/or trivalent binding proteins comprising four polypeptide chains that form three antigen binding sites that...
2017/0320966 HUMANIZED MONOCLONAL ANTIBODY AND USES THEREOF
A humanized monoclonal antibody against the CD34 surface antigen is provided in the present disclosure. The humanized monoclonal antibody includes a light...
2017/0320965 PAN-REACTIVE ANTIBODIES TO DUOCARMYCINS
The present invention relates to a monoclonal, pan-reactive antibody to duocarmycins. The monoclonal, pan-reactive antibody of the present invention may be...
2017/0320964 Modulators of ACYL-COA Lysocardiolipin Acyltransferase 1 (ALCAT1) and Uses Thereof
Compositions of modulators of acyl-CoA lysocardiolipin acyltransferase 1 (ALCAT1) expression, function or activity are provided. In particular, inhibitors of...
2017/0320963 Genetic Products Differentially Expressed In Tumors And The Use Thereof
The present technology relates to the identification of genetic products expressed in association with tumors and to coding nucleic acids for the expressed...
2017/0320962 MONOCLONAL ANTIBODIES AGAINST C-MET
Isolated monoclonal antibodies which bind to human c-Met, the hepatocyte growth factor receptor, and related antibody-based compositions and molecules, are...
2017/0320961 Anti-CD38 Antibodies for Treatment of Acute Lymphoblastic Leukemia
The present invention relates to combination therapies with anti-CD38 antibodies.
2017/0320960 NOVEL ANTI-MFI2 ANTIBODIES AND METHODS OF USE
Provided are novel anti-MFI2 antibodies and antibody drug conjugates, and methods of using such anti-MFI2 anti-bodies and antibody drug conjugates to treat...
2017/0320959 ICOS LIGAND VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
Provided herein are immunomodulatory proteins comprising ICOSL variants and nucleic acids encoding such proteins. The immunomodulatory proteins provide...
2017/0320958 MULTIVALENT AND MULTISPECIFIC GITR-BINDING FUSION PROTEINS
This disclosure generally provides molecules that specifically engage glucocorticoid-induced TNFR-related protein (GITR), a member of the TNF receptor...
2017/0320957 Methods of Inhibiting Activity Using Anti-CD27 Antibodies
Human antibodies immunospecific for human CD27 are capable of blocking CD27 binding to its ligand CD70 and neutralizing bioactivity of CD27 including, but not...
2017/0320956 ANTI-LIGHT ANTIBODIES
The present invention relates to anti-human LIGHT antibodies, new medical uses and methods.
2017/0320955 TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY RECEPTOR BINDING MOLECULES AND USES THEREOF
This disclosure provides dimeric, pentameric, and hexameric Tumor Necrosis Factor (TNF) superfamily receptor protein binding molecules and methods of using...
2017/0320954 THERAPEUTIC COMBINATIONS AND METHODS FOR TREATING NEOPLASIA
The disclosure features a CXCR2 antagonist in combination with a checkpoint inhibitor (e.g., an anti-CTLA-4 antibody or an anti-PD-L1 antibody) and methods of...
2017/0320953 ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF
The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing...
2017/0320952 METHODS OF TREATING CANCER WITH ANTIBODIES THAT TARGET THE INSULIN-LIKE GROWTH FACTOR TYPE I RECEPTOR (IGF-1R)
The present invention provides compositions and methods of use of anti-IGF-1R antibodies or antibody fragments. Preferably the antibodies bind to IGF-1R but...
2017/0320951 METHODS FOR DIAGNOSING AND TREATING CD1D RESTRICTED GAMMA/DELTA T CELL LYMPHOMAS
Methods for diagnosing and treating CD1d-restricted gamma/delta T cell lymphomas are disclosed. In particular, the present disclosure relates to a method for...
2017/0320950 Anti-Vista Antibodies And Fragments, Uses Thereof, And Methods Of Identifying Same
The present invention relates to antibodies and fragments that bind to a V-domain Ig Suppressor of T cell Activation (VISTA), and methods of eliciting certain...
2017/0320949 THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES COMPRISING PD-1 AGONIST
Provided is a prophylactic, symptom progress-suppressive, and/or therapeutic agent for an autoimmune disease. The agent lowers the risk of infections and...
2017/0320948 Anti-CD3 Antibodies, Bispecific Antigen-Binding Molecules That Bind CD3 And CD20, And Uses Thereof
The present invention provides antibodies that bind to CD3 and methods of using the same. According to certain embodiments, the antibodies of the invention...
2017/0320947 HETERODIMERIC ANTIBODIES THAT BIND CD3 AND PSMA
The present invention is directed to heterodimeric antibodies that bind CD3 and PSMA.
2017/0320946 RECEPTOR TREM (TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS) AND USES THEREOF
Novel activating receptors of the Ig super-family expressed on human myeloid cells, called TREM(s) (triggering receptor expressed on myeloid cells) are...
2017/0320945 Methods for Manipulating Phagocytosis Mediated by CD47
Methods are provided to manipulate phagocytosis of cells, including hematopoietic cells, e.g. circulating hematopoietic cells, bone marrow cells, acute...
2017/0320944 ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS
Disclosed are antibodies, including antibody drug conjugates, that specifically bind to NTB-A. Also disclosed are methods for using the anti-NTB-A antibodies...
2017/0320943 BISPECIFIC MOLECULE BINDING TLR9 AND CD32 AND COMPRISING A T CELL EPITOPE FOR TREATMENT OF ALLERGIES
A molecule or molecule complex capable of binding to TLR9 and to CD32 comprising at least one epitope of at least one antigen, and its use a medicament for the...
2017/0320942 BISPECIFIC MOLECULE BINDING TLR9 AND CD32 AND COMPRISING A T CELL EPITOPE FOR TREATMENT OF ALLERGIES
A molecule or molecule complex capable of binding to TLR9 and to CD32 comprising at least one epitope of at least one antigen, and its use a medicament for the...
2017/0320941 CS1-SPECIFIC CHIMERIC ANTIGEN RECEPTOR ENGINEERED IMMUNE EFFECTOR CELLS
Disclosed herein are chimeric antigen receptors (CAR) that can specifically recognize tumor-associated antigens (TAA) on multiple myeloma (MM) cells. Also...
2017/0320940 ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND METHODS OF USE
The present invention relates to anti-alpha-synuclein (anti-.alpha.-synuclein) antibodies and methods of using the same.
2017/0320939 COLL2-1 PEPTIDE AND ITS NITRATED FORM AS THERAPEUTIC TARGETS FOR OSTEOARTHRITIS TREATMENT
The present invention provides a medicament comprising as active ingredient an inhibitor of Coll2-1 peptide activity and/or an inhibitor of Coll2-1NO.sub.2...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.